Hong Kong
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 493.46 M
|
Dec. 31, 2023 | USD 0.67 | 1.53% |
|
Hong Kong |
|
2 |
USD 122.31 M
|
March 31, 2024 | USD 0.43 | 2.74% |
|
Hong Kong |
|
3 |
USD 69.19 M
|
Dec. 31, 2023 | USD 1.04 | 1.48% |
|
Hong Kong |
|
4 |
USD 45.92 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
5 |
USD 38.07 M
|
Dec. 31, 2023 | USD 0.44 | -0.60% |
|
Hong Kong |
|
6 |
USD 34.11 M
|
March 31, 2024 | USD 0.13 | 1.98% |
|
Hong Kong |
|
7 |
USD 20.87 M
|
Dec. 31, 2023 | USD 0.18 | -0.02% |
|
Hong Kong |
|
8 |
USD 16.67 M
|
March 31, 2024 | USD 0.22 | -1.75% |
|
Hong Kong |
The Drugstores & Retail Pharmacies company in Hong Kong with the highest Net Income is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at USD 493.46 M.
The Drugstores & Retail Pharmacies company in Hong Kong with the lowest Net Income is JBM (Healthcare) Limited (HKSE: 2161.HK) at USD 16.67 M.
The top 10 Drugstores & Retail Pharmacies companies in Hong Kong by Net Income are China Resources Pharmaceutical Group Limited, Alibaba Health Information Technology Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited, Dawnrays Pharmaceutical (Holdings) Limited, Tycoon Group Holdings Limited, Jacobson Pharma Corporation Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited and JBM (Healthcare) Limited.
The bottom 10 Drugstores & Retail Pharmacies companies in Hong Kong by Net Income are JBM (Healthcare) Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Jacobson Pharma Corporation Limited, Tycoon Group Holdings Limited, Dawnrays Pharmaceutical (Holdings) Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited, Alibaba Health Information Technology Limited and China Resources Pharmaceutical Group Limited.